The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A three-dimensional human neural cell culture model of Alzheimer’s disease
Open accessAbstract
Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beading or blebbing in neurites is a marker of dystrophic neurites in the AD brain (3, 42, 43).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD, tau protein becomes hyperphosphorylated, resulting in tau dissociating from microtubules and forming insoluble tau aggregates in the neurites and cell bodies (3, 37).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In iPSC-derived neurons from both FAD- and SAD-patients, pTau aberrantly accumulates at early time points (Choi et al., 2014, Israel et al., 2012, Moore et al., 2015, Muratore et al., 2014, Ochalek et al., 2017, Shi et al., 2012).”
From Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons (2019) · cites this paper as Choi et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Modeling these pathological hallmarks has largely relied on transgenic cellular and animal models harboring genetic mutations linked to ADAD (3–5).”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“As for human neurons, previous studies focused on overexpressing mutant APP and Presenilin in REN stem cells grown in a 3D culture (3), which differs from patient-specific LOAD model that relies on the endogenous recapitulation of AD-associated phenotypes as provided in this study.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [3]
In the citing paper
“one study revealed that familial AD (FAD) mutations in β-amyloid precursor protein and presenilin 1 induced robust extracellular deposition of amyloid-β in a human neural stem-cell-derived 3D culture system85.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“the 3D-differentiated neuronal cells expressing FAD mutations exhibited aggregates of phosphorylated tau as well as filamentous tau.”
From The use of brain organoids to investigate neural development and disease (2017) · cites this paper as [85]
In the citing paper
“A 3D in vitro culture system consisting of human neurons differentiated from induced pluripotent stem cells overexpressing human APP containing FAD mutations generates robust Aβ42 production and amyloid deposition. Importantly, this model also develops elevated phospho-tau levels and fibrillary tau aggregates, suggesting that elevated Aβ levels alone are sufficient to drive tau pathology in human”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Choi et al., 2014
In the citing paper
“It was recently shown that development of a 3D culture of human neural stem cells transfected with APPK670N/M671L/V717I and PS1ΔE9 in Matrigel scaffolding resulted in the extracellular aggregation of Aβ into plaques and the intracellular aggregation of tau in dystrophic neurites and the cell soma [23, 77].”
From Alzheimer's disease: experimental models and reality (2017) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Self-citationProbing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
Cohen, R. M., Rezai-Zadeh, K. P., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I. E., Bholat, Y., Vasilevko, V., Glabe, C. G., Breunig, J. J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3672-12.2013 · Cited by 555
Muratore, C. R., Rice, H. C., Srikanth, P., Callahan, D. G., Shin, T., Benjamin, L. N. P., Walsh, D. M., Selkoe, D. J., & Young-Pearse, T. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu064 · Cited by 379
Flagged first, then by citations
Research works printed but not linked: 1
- Higuchi, M., Trojanowski, J. Q. & Lee, V. M.-Y. Tau protein and tauopathy. Neuropsychopharmacology: The Fifth Generation of Progress (eds Davis, K. L., Charney, D., Coyle, J. T. & Nemeroff, C. ) 1339–1354 (Lippincott, Williams & Wilkins, 2002)
Cited by
Sorted by citations
Items 701–800 of 998
Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
Ovchinnikov, D. A., & Wolvetang, E. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041357 · Cited by 13
A Novel Three-Dimensional Culture System for Oligodendrocyte Precursor Cells
Egawa, N., Shindo, A., Liang, A. C., Du, Y., Xing, C., Lo, E. K., Itoh, K., Kinoshita, H., Maki, T., Takahashi, R., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0306 · Cited by 13
Lim, H. J., Khan, Z., Lu, X., Perera, T. H., Wilems, T. S., Ravivarapu, K., & Callahan, L. A. S. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.001 · Cited by 13
Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Edginton, T. L., Hinz, R., Win, Z., Brooks, D. J., & Edison, P. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181168 · Cited by 13
Modeling neurodegenerative diseases with brain organoids: from development to disease applications
Larriba-González, T., García-Martín, M., Ojeda-Hernández, D. D., Rincón-Cerrada, P., Martín-Blanco, L., Benito‐Martín, M. S., Selma-Calvo, B., de la Fuente-Martín, S., Matías‐Guiu, J. A., Matías‐Guiu, J., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1663286 · Cited by 12
Emerging Three‐Dimensional Integrated Systems for Biomimetic Neural In Vitro Cultures
Seiti, M., Ginestra, P. S., Ceretti, E., Ferraris, E., & Ranga, A. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202101297 · Cited by 13
Cuní‐López, C., Stewart, R., White, A. R., & Quek, H. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578017 · Cited by 9
Traldi, C., Chiappini, V., Menduti, G., Tonda‐Turo, C., & Boido, M. (2023) · Frontiers in Medical Engineering · doi:10.3389/fmede.2023.1270943 · Cited by 12
Live-cell visualization of tau aggregation in human neurons
Hurtle, B. T., Donnelly, C. J., Zhang, X., & Thathiah, A. (2024) · Communications Biology · doi:10.1038/s42003-024-06840-z · Cited by 12
Reprogramming cells from Gulf War veterans into neurons to study Gulf War illness
Qiang, L., Rao, A. N., Mostoslavsky, G., James, M. F., Comfort, N. T., Sullivan, K. A., & Baas, P. W. (2017) · Neurology · doi:10.1212/wnl.0000000000003938 · Cited by 12
Mollica, P. A., Zamponi, M., Reid, J. A., Sharma, D. K., White, A. E., Ogle, R. C., Bruno, R. D., & Sachs, P. C. (2018) · Journal of Cell Science · doi:10.1242/jcs.215343 · Cited by 12
Generation of human midbrain organoids from induced pluripotent stem cells
Mohamed, N., Mathur, M., da Silva, R. V., Thomas, R. A., Lépine, P., Durcan, T. M., Fon, E. A., & Durcan, T. M. (2019) · MNI Open Research · doi:10.12688/mniopenres.12816.1 · Cited by 26
Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease
Wasielewska, J. M., Chaves, J., White, A. R., & Oikari, L. E. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch7 · Cited by 13
Welty, S., Thathiah, A., & Levine, A. S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220030 · Cited by 13
Chen, H., Seaman, L., Liu, S., Ried, T., & Rajapakse, I. (2017) · Nucleus · doi:10.1080/19491034.2017.1280209 · Cited by 12
Self-citationTesting the Amyloid Hypothesis with a Humanized AD Mouse Model
Cahill, M. K., & Huang, E. J. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.044 · Cited by 12
Srinivasan, G. R., Morgan, D., Varun, D., Brookhouser, N., & Brafman, D. A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.008 · Cited by 12
Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?
Prytkova, I., Goate, A., Hart, R. P., & Slesinger, P. A. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13811 · Cited by 12
Relationship Between Tau, β Amyloid and α-Synuclein Pathologies
Walker, L., & Attems, J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_14 · Cited by 12
Urolithin-A attenuates neurotoxoplasmosis and alters innate response towards predator odor
Tan, S., Tong, W. H., & Vyas, A. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100128 · Cited by 12
Late-life sleep duration associated with amnestic mild cognitive impairment
Yuan, M., Hong, B., Zhang, W., Liu, A., Wang, J., Liu, Y., Feng, Y., Xiao, S., Xu, H. J., & Wang, T. (2021) · International Psychogeriatrics · doi:10.1017/s1041610221000466 · Cited by 12
Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
Guo, X., Wang, X., Wang, J., Ma, M., & Ren, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083774 · Cited by 15
McInvale, J. J., Canoll, P., & Hargus, G. (2024) · Brain Pathology · doi:10.1111/bpa.13231 · Cited by 11
Human-Derived Brain Models: Windows into Neuropsychiatric Disorders and Drug Therapies
Papariello, A. R., & Litwa, K. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.922 · Cited by 11
Kuhlmann, N., Valladolid, M. W., Quesada-Ramírez, L., Farrer, M. J., & Milnerwood, A. J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.569031 · Cited by 14
Kang, S., Joshi, P., & Lee, M. (2021) · Current Protocols · doi:10.1002/cpz1.107 · Cited by 11
Kubelt, C., Molkewehrum, H., Lucius, R., Synowitz, M., Held‐Feindt, J., & Helmers, A. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-021-08674-y · Cited by 11
Muzzi, L., Lisa, D. D., Falappa, M., Pepe, S., Maccione, A., Pastorino, L., Martinoia, S., & Frega, M. (2022) · Bioengineering · doi:10.3390/bioengineering10040449 · Cited by 14
McMurtrey, R. J. (2016) · Journal of Tissue Engineering · doi:10.1177/2041731416671926 · Cited by 13
Effects of Species-Specific Genetics on Alzheimer’s Mouse Models
Hyman, B. T., & Tanzi, R. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.021 · Cited by 11
Self-citationDisease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models
Kaindl, J., & Winner, B. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_111 · Cited by 12
Alzheimer’s Disease Prevention and Treatment: Case for Optimism
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1008 · Cited by 11
D’Avanzo, C., Sliwinski, C., Wagner, S. L., Tanzi, R. E., Kim, D. Y., & Kovacs, D. M. (2015) · The FASEB Journal · doi:10.1096/fj.15-271015 · Cited by 11
Self-citationBrain Aggregates: An EffectiveIn VitroCell Culture System Modeling Neurodegenerative Diseases
Ahn, M., Kalume, F. K., Pitstick, R., Oehler, A., Carlson, G. A., & DeArmond, S. J. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv025 · Cited by 11
Ward, J. F., Wang, H., Saunders, A. J., Tanzi, R. E., & Zhang, C. M. (2017) · PubMed · Cited by 11
Self-citationGiudice, M. L., Mihalik, B., Turi, Z., Dinnyés, A., & Kobolák, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190602 · Cited by 11
The Emerging Role of Innate Immunity in Alzheimer’s Disease
Kumar, D. K. V., & Moir, R. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.226 · Cited by 11
Prevention of Alzheimer's Disease in Chinese Populations: Status, Challenges and Directions
Feng, L., Li, J., Yu, J., Zhang, C., Yang, B., Vellas, B. J., & Li, C. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.14 · Cited by 11
Self-citationBöröczky, C., Paszternák, A., Laufer, R., Tarnóczi, K., Sikur, N., Bagaméry, F., Szökő, É., Varga, K., & Tábi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146581 · Cited by 11
Zheng, Y., Zhou, W., Chang, H., & Zheng, K. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1764964 · Cited by 12
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Long-term in vitro culture of 3D brain tissue model based on chitosan thermogel
Lisa, D. D., Muzzi, L., Lagazzo, A., Andolfi, A., Martinoia, S., & Pastorino, L. (2023) · Biofabrication · doi:10.1088/1758-5090/ad0979 · Cited by 11
Irisin limits amyloid-β buildup in Alzheimer’s disease
Lourenco, M. V. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.11.006 · Cited by 14
Approaches for studying neuroimmune interactions in Alzheimer’s disease
Lin, C., Tian, Y., Tanzi, R. E., & Jorfi, M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.10.002 · Cited by 11
Self-citationMaity, A., Maidantchik, V. D., Weidenfeld, K., Larisch, S., Barkan, D., & Haick, H. (2025) · Advanced Materials · doi:10.1002/adma.202413017 · Cited by 10
Kasmi, N., Pieruccioni, L., Pitot, E., Fourquaux, I., Wodrinski, A., Gibot, L., & Fitremann, J. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02658f · Cited by 10
Alzheimer’s Disease Drug Development: A Research and Development Ecosystem
Cummings, J. L., Kinney, J. W., & Fillit, H. M. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.002 · Cited by 10
Hasan, M. F., & Trushina, E. V. (2022) · Brain Sciences · doi:10.3390/brainsci12050552 · Cited by 10
Young, J. E., & Goldstein, L. S. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_6 · Cited by 10
Park, S.-J., & Choi, J. (2023) · BioChip Journal · doi:10.1007/s13206-023-00107-1 · Cited by 11
Norambuena, A., Sagar, V. K., Wang, Z., Raut, P., Feng, Z., Wallrabe, H., Pardo, E., Kim, T., Alam, S. R., Hu, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14144 · Cited by 10
EXPERIMENTAL MODELS OF ALZHEIMER’S DISEASE: ADVANTAGES AND DISADVANTAGES
Iptyshev, A. M., Gorina, Y. V., Lopatina, O. L., Komleva, Y. K., & Salmina, A. B. (2016) · Siberian medical review · doi:10.20333/25000136-2016-4-5-21 · Cited by 10
Bignoux, M. J., Cuttler, K., Otgaar, T. C., Ferreira, E., Letsolo, B. T., & Weiss, S. F. T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190075 · Cited by 9
A simple human cell model for TAU trafficking and tauopathy-related TAU pathology
Bell, M. J., & Zempel, H. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322450 · Cited by 11
Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture
Ismael, S., Sindi, G., Colvin, R. A., & Lee, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101108 · Cited by 12
Langlie, J. A., Mittal, R., Finberg, A., Bencie, N. B., Mittal, J., Omidian, H., Omidi, Y., & Eshraghi, A. A. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335836 · Cited by 10
Recent Advances from the Bench Toward the Bedside in Alzheimer's Disease
Macauley, S. L., & Holtzman, D. M. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.002 · Cited by 10
Ren, T., Grosshäuser, B., Sridhar, K., Nieland, T. J. F., Tocchio, A., Schepers, U., & Demirci, U. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.017 · Cited by 11
Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition
Rowland, H. A., Moxon, S. R., Corbett, N. J., Hanson, K., Fisher, K., Kellett, K. A. B., & Hooper, N. M. (2023) · Neuronal Signaling · doi:10.1042/ns20230016 · Cited by 15
Ouyang, A., Zhang, C. M., Adra, N., Tesh, R. A., Sun, H., Lei, D., Jing, J., Fan, P., Paixão, L. G. P., Ganglberger, W., et al. (2024) · Life · doi:10.3390/life14070855 · Cited by 13
Self-citationLocus coeruleus tau is linked to successive cortical tau accumulation
Yi, D., Byun, M. S., Jung, J. H., Jung, G., Ahn, H., Chang, Y. Y., Keum, M., Lee, J., Lee, Y., Kim, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14426 · Cited by 8
Self-citationMishra, S., Mondal, G., & Kumarasamy, M. (2025) · Organoids · doi:10.3390/organoids4020013 · Cited by 9
Adak, S., Singh, S., Jain, R., Tiwari, A., Singh, B., Kumar, S., Dadhwal, A., Chakroborty, A., Sharma, A. K., Singh, R. P., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1646551 · Cited by 12
Human brain organoids: an innovative model for neurological disorder research and therapy
Li, H., Zhu, J., Li, J., Wu, Y., Luo, C., Huang, Y., Wu, J., Liu, W., Wang, H., & Mo, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1658074 · Cited by 11
Kemppainen, N. M., Joutsa, J., Johansson, J. J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R. K., & Rinne, J. O. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150190 · Cited by 9
Rab-mediated membrane trafficking and the control of epithelial cell polarity
Ioannou, M. S., & McPherson, P. S. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201604076 · Cited by 9
Dong, J., Duchesne, A., Bayne, A. N., Mohamed, N., Yi, W., Mathur, M., Chen, C. X. ‐., You, Z., Abdian, N., Taylor, L., et al. (2022) · Methods · doi:10.1016/j.ymeth.2022.03.011 · Cited by 9
Emerging three-dimensional neuronal culture assays for neurotherapeutics drug discovery
Rathore, R. S., Ayyannan, S. R., & Mahto, S. K. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2061458 · Cited by 8
GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation
Todd, N., Huang, Y., Lee, J. Y., Doruker, P., Krieger, J., Salisbury, R., MacDonald, M. L., Bahar, İ., & Thathiah, A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111110 · Cited by 10
Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
Pinals, R. L., & Tsai, L. (2022) · Life Science Alliance · doi:10.26508/lsa.202201542 · Cited by 10
Functional bioengineered tissue models of neurodegenerative diseases
Mullis, A. S., & Kaplan, D. L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122143 · Cited by 10
Soares, E. S., Velasco, C. D., Tarrasón, A., Soler, M., Srinivas, T., Setién, F., Oliveira-Mateos, C., Casado-Peláez, M., Martinez‐Verbo, L., Armstrong, J., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf074 · Cited by 9
del Rı́o, J. A., & Ferrer, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.570692 · Cited by 8
Volloch, V., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1009 · Cited by 10
Patterning of interconnected human brain spheroids
Kim, J. J., Jorfi, M., Tanzi, R. E., Kim, D. Y., Doyle, P. S., & Irimia, D. (2021) · Lab on a Chip · doi:10.1039/d0lc01112f · Cited by 9
Self-citationKumar, D., & Hassan, M. I. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.040 · Cited by 9
Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
Yoshida, S., & Hasegawa, T. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105307 · Cited by 9
Alzheimer's Disease Drug Development
(2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759 · Cited by 9
Liu, S., Zhu, P., Tian, Y., Chen, Y., Liu, Y., Chen, W., Du, L., & Wu, C. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28109 · Cited by 9
Alexopoulos, P., & Kurz, A. (2015) · Psychopathology · doi:10.1159/000441327 · Cited by 10
Liu, Y., Zhan, L., Bi, T.-T., Liang, L., Sun, X., & Sui, H. (2016) · RSC Advances · doi:10.1039/c6ra04370d · Cited by 10
The Genetic Basis of Alzheimer's Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00034-2 · Cited by 9
Self-citationModelling neurodegenerative diseases in vitro: Recent advances in 3D iPSC technologies
Siney, E. J., Kurbatskaya, K., Chatterjee, S., Prasannan, P., Mudher, A. K., & Willaime‐Morawek, S. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.1.1 · Cited by 9
Heat Shock Proteins and Protein Quality Control in Alzheimer’s Disease
van Leeuwen, F. W., & Kampinga, H. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00010-9 · Cited by 9
Liu, X., Zhou, C., & Fang, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.029 · Cited by 9
A Human Embryonic Stem Cell Model of Aβ-Dependent Chronic Progressive Neurodegeneration
Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01007 · Cited by 9
Chandrashekar, H., Simándi, Z., Choi, H., Ryu, H.-S., Waldman, A. J., Nikish, A., Muppidi, S. S., Gong, W., Paquet, D., & Phillips‐Cremins, J. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582395 · Cited by 10
Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine
Karam, M., Ortega-Gascó, A., & Tornero, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073275 · Cited by 10
Tau aggregation induces cell death in iPSC-derived neurons
Tanabe, H., Maeda, S., Sano, E., Sakai, N., Endoh‐Yamagami, S., & Okano, H. (2025) · Aging Brain · doi:10.1016/j.nbas.2025.100136 · Cited by 9
Cryopreserving 3D cell culture models of Alzheimer’s disease in hydrogel microbeads
Kim, J. J., Hebisch, M., Kwak, S. S., Zheng, M., Nuli, S. S., Bae, J., Brand, E., Tanzi, R. E., Irimia, D., & Kim, D. Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-94810-8 · Cited by 8
Self-citationOne‐Step Drug Screening System Utilizing Electrophysiological Activity in Multiple Brain Organoids
Shin, H., An, Y., Lee, J., Kim, J. H., Prasad, R., Kim, K., Kang, H., Sun, W., Cho, S., & Cho, I. (2025) · Advanced Science · doi:10.1002/advs.202504913 · Cited by 8
A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease
Becerra-Calixto, A., Banerjee, A., Fan, H., Tan, C., Lee, E., McCullough, L. D., & Lee, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03544-x · Cited by 10
Harnessing induced pluripotent stem cells and organoids for disease modeling and precision medicine
Lee, C.-J., Nam, Y., Rim, Y. A., & Ju, J. H. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-04906-9 · Cited by 8
Olson, M. N., Dawes, P., Murray, L. F., Barton, N., Sundstrom, J., Orszulak, A. R., Chigas, S. M., Tran, K., Aylward, A. J., Caliandro, M. F., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00066-y · Cited by 7
Halonen, S. K. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1129451 · Cited by 8
A narrative review of organoids for investigating organ aging: opportunities and challenges
Sun, X., Sun, F., Zhang, Y., Qu, J. T., Zhang, W., & Liu, G. (2023) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000139 · Cited by 8
Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery
Patil, V. M., Masand, N., Gautam, V., Kaushik, S., & Wu, D. H. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_13 · Cited by 9
Development of an accelerated cellular model for early changes in Alzheimer’s disease
Xue, H., Gate, S., Gentry, E., Losert, W., & Cao, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-45826-5 · Cited by 8
New approaches for understanding the potential role of microbes in Alzheimer's disease
Whitson, H. E., Banks, W. A., Diaz, M. M., Frost, B. E., Kellis, M., Lathe, R., Schmader, K. E., Spudich, S., Tanzi, R. E., & Garden, G. A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100743 · Cited by 8
Self-citationOn the Inadequacy of the Current Transgenic Animal Models of Alzheimer’s Disease: The Path Forward
Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052981 · Cited by 9
Metadata
- Authors
- Choi, S. H., Kim, Y. H., Hebisch, M., Sliwinski, C., Lee, S., D’Avanzo, C., Chen, H., Hooli, B., Asselin, C., Muffat, J., Klee, J. B., Zhang, C., Wainger, B. J., Peitz, M., Kovacs, D. M., Woolf, C. J., Wagner, S. L., Tanzi, R. E., & Kim, D. Y.
- Affiliations
- Harvard University (US)
- University of Bonn (DE)
- Boston Children's Hospital (US)
- Whitehead Institute for Biomedical Research (US)
- University of California San Diego (US)
- Corresponding author
- Tanzi, Rudolph E.
- Kim, Doo Yeon
- ORCID
- Venue
- Nature
- Published
- 2014-10-12
- Volume
- 515
- Issue
- 7526
- Pages
- 274-278
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4366007
- OpenAlex
- W2126231259
- Cited by
- 1,195
- References
- 30
- Citations by year
- 2026: 67 · 2025: 75 · 2024: 95 · 2023: 88 · 2022: 112 · 2021: 111 · 2020: 141 · 2019: 109 · 2018: 109 · 2017: 87 · 2016: 97 · 2015: 87 · 2014: 14
- FWCI
- 63.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Massachusetts General Hospital
- Cure Alzheimer's Fund
- University of Edinburgh
- National Institute on Aging (5P01 AG15379, P01AG015379, R21AG031483, RF1AG048080, P50AG005134, R01AG014713, P01AG004953, P30AG062421)
- National Institute of Mental Health (R37MH060009)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK043351)
- National Institute of Neurological Disorders and Stroke (P30NS045776, R01NS045860)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD018655)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, familial Alzheimer's disease, amyloid plaques, tauopathy, neurofibrillary tangles, amyloid hypothesis, presenilin 1 mutations, human neural stem cells, 3D cell culture, human neurons, beta-secretase inhibition, gamma-secretase inhibition, tau phosphorylation, drug screening model
- MeSH terms
- Alzheimer Disease, Cell Differentiation, Drug Evaluation, Preclinical, Extracellular Space, Humans, Microtubule-Associated Proteins, Models, Biological, Phosphorylation, Reproducibility of Results, Amyloid beta-Peptides, Neurites, tau Proteins, Cell Culture Techniques, Glycogen Synthase Kinase 3, Presenilin-1, Neural Stem Cells, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
